No price history available.

Based on consensus from external analysts. Not Kvantra's opinion.

Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics in the United Kingdom. It operates in two segments: Hospitals Business and Primary Care. The company provides diagnostics, inpatient, day case, and outpatient care in areas, including orthopedics, gynaecology, cardiology, neurology, oncology, and general surgery; and primary care needs of outpatients, such as GP services, occupational health services, and mental and physical health services. It also offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, digestive and bowel treatments, breast screening and surgery, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments. In addition, the company provides eye surgery and treatments, family planning, gastroenterology, general medicine, haematology, hand surgery, hip and knee replacement treatment, and heart and kidney treatments. Further, it offers treatments in the areas of men's health, neurosurgery and neurology, paediatrics, pain management, rehabilitation, sports, physiotherapy, podiatry, respiratory medicine, and rheumatology; and scans and investigations, skin treatments, spinal neurosurgery, sports science, urology, vascular surgery, weight loss, and women's health. Additionally, the company provides treatments in the areas of breast enlargement, cataract removal surgery, gastric bypass surgery, and prostate surgery; and offers various tests and scans, which include cardiac CT, CT, MRI, ultrasound, and X-ray scans. Spire Healthcare Group plc was founded in 2007 and is headquartered in London, the United Kingdom.

• Ambea AB (publ)
• Summerset Group Holdings Limited
• CVS Group plc
• National Medical Care Company
• U.S. Physical Therapy, Inc.
• Al Hammadi Holding Company
• RHON-KLINIKUM AG Unsponsored ADR
• Regis Healthcare Limited